Maruggi, Giulietta
GlaxoSmithKline (United States)
3 papers on CoChatORCID 0000-0002-3877-3434
Most cited papers
- Verified
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Maruggi, G., Zhang, C., Li, J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy
RNA Interference and Gene DeliveryImmunotherapy and Immune Responses
Cited by 507
- Verified
Induction of an IFN-mediated antiviral response by a self-amplifying RNA vaccine: implications for vaccine design
Pepini, T., Pulichino, A.-M., Carsillo, T., Carlson, A. L., Sari-Sarraf, F., Ramsauer, K., Debasitis, J. C., Maruggi, G., Otten, G. R., Geall, A. J., et al. (2017) · The Journal of Immunology
Immunotherapy and Immune Responsesinterferon and immune responses
Cited by 208
- Verified
Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens
Maruggi, G., Chiarot, E., Giovani, C., Buccato, S., Bonacci, S., Frigimelica, E., Margarit, I., Geall, A., Bensi, G., & Maione, D. (2017) · Vaccine
RNA Interference and Gene DeliveryImmunotherapy and Immune Responses
Cited by 149
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free